Clinical Effects of Oral Valiltramiprosate Treatment in APOE4 Carriers with Mild Cognitive Impairment (MCI): Results of the Phase 2 Study Long-term Extension over 3 Years

Biophysical Characterization of Phosphatidylinositol 3-Kinase-? as a Drug Target: Implications for the Development of Potent Inhibitory Drug Molecules for Alzheimer’s Disease